C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 9/68 (2006.01) C12N 15/09 (2006.01)
Patent
CA 2707266
Polynucleotides and polypeptides relating to a recombinantly-modified plasmin(ogen) molecule are provided. The plasmin(ogen) molecule has a single kringle domain N-terminal to the activation site present in the native human plasminogen molecule, combined such that no foreign sequences are present, and exhibits lysine-binding and significant enzymatic characteristics associated with the native enzyme.
L'invention concerne des polynucléotides et des polypeptides apparentés à une molécule de plasmine (plasminogène) modifiée de manière recombinante. La molécule de plasmine (plasminogène) a une extrémité N-terminale à domaine kringle unique vers le site d'activation présent dans la molécule de plasminogène humaine native, combinée de telle sorte qu'il n'y a pas de séquences étrangères, et présente une liaison à la lysine et des caractéristiques enzymatiques significatives associées à l'enzyme native.
Borden Ladner Gervais Llp
Talecris Biotherapeutics Inc.
LandOfFree
Recombinantly modified plasmin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinantly modified plasmin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinantly modified plasmin will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2070767